{"nct_id":"NCT03541369","title":"Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2018-09-14","start_date_type":"ACTUAL","primary_completion_date":"2023-02-21","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}